Welcome to our dedicated page for Spectral AI SEC filings (Ticker: MDAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading a 300-page filing packed with clinical trial tables and FDA risk factors is a challenge—especially when Spectral AI’s DeepView System sits at the cutting edge of predictive diagnostics. If you have ever searched for Spectral AI insider trading Form 4 transactions or wondered how to locate a Spectral AI quarterly earnings report 10-Q filing, you already know the pain of navigating EDGAR.
Stock Titan solves that problem. Our AI-powered analysis engine delivers Spectral AI SEC filings explained simply, breaking down revenue from grants versus device sales, clarifying R&D outlays, and flagging regulatory milestones. You will find every form in real time, from Spectral AI Form 4 insider transactions real-time to an Spectral AI annual report 10-K simplified. Need quick context on a sudden announcement? The platform pairs each submission with concise AI summaries, turning dense documents into digestible insights—ideal for understanding Spectral AI SEC documents with AI.
Practical use cases abound: compare clinical spend trends through Spectral AI earnings report filing analysis; track management incentives inside the Spectral AI proxy statement executive compensation; or spot material catalysts via Spectral AI 8-K material events explained. Our real-time alerts on Spectral AI executive stock transactions Form 4 help you monitor insider sentiment before critical FDA updates. With comprehensive coverage, instant AI highlights, and historical search, Stock Titan turns every Spectral AI disclosure into a strategic advantage.
Spectral AI (MDAI) completed a financing that raised approximately $7,600,000 through a registered direct offering and a concurrent private placement. The company sold 3,065,000 registered shares at $1.90 per share under its effective S-3, and, in a private placement, issued warrants to purchase up to 4,000,000 shares at $2.51 and pre-funded warrants to purchase up to 935,000 shares at a $0.0001 exercise price.
The warrants become exercisable on the earlier of stockholder approval or six months from issuance and expire five years after issuance, with a 4.99% beneficial ownership cap (adjustable up to 9.99% after 61 days). Pre-funded warrants are immediately exercisable with a 9.99% cap (adjustable as stated). Closing occurred on October 24, 2025. Northland acted as placement agent on a reasonable best efforts basis; its cash fee is 6.00% of gross proceeds from the share sale. The company plans to use net proceeds for working capital and general corporate purposes and agreed to file a resale registration within 10 days pursuant to a registration rights agreement.
Spectral AI, Inc. (Nasdaq: MDAI) is registering and offering 3,065,000 shares of common stock at $1.90 per share in a registered direct offering. The company expects net proceeds of approximately $5.1 million after fees and expenses and plans to use the funds for working capital and general corporate purposes.
In a concurrent private placement, the company is also selling pre-funded warrants to purchase up to 935,000 shares at an exercise price of $0.0001 per share and warrants to purchase up to 4,000,000 shares at an exercise price of $2.51 per share; these securities and their underlying shares are not registered here. Northland Securities, Inc. is acting as sole placement agent on a reasonable best efforts basis. Shares outstanding were 27,623,895 as of October 22, 2025, and are expected to be 30,688,895 after this offering. The company cites public float of approximately $52.1 million and states current S-3 capacity under General Instruction I.B.6 to offer up to approximately $11.1 million.
FAQ
What is the current stock price of Spectral AI (MDAI)?
What is the market cap of Spectral AI (MDAI)?
